EQS-News: Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need

Issuer: Immunic, Inc. / Key word(s): Miscellaneous Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need 09.02.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Host Virtu...

Related Keywords

Berlin ,Germany ,Russia ,Ukraine ,Edna Kaplan ,Hella Kohlhof ,Michael Schumann ,Paula Schwartz ,Benjamin Franklin ,Daniel Vitt ,Jessica Breu ,Andreas Muehler ,Josepha Murray ,Department Of Internal Medicine ,Shirley Berry Professor Of Gastrointestinal Sciences ,Division Of Gastroenterology ,Department Of Gastroenterology ,Rx Communications Group ,Nasdaq ,Distribution Services ,Celiac Disease Research ,Exchange Commission ,Immunic Inc ,Highlight Current Pathways ,Drug Development ,Unmet Medical Need ,Unmet Medical ,Conference Call ,Held Today ,Celiac Disease Rd Webcast ,Chief Executive Officer ,Chief Medical Officer ,Chief Scientific Officer ,Shirley Berry Professor ,Gastrointestinal Sciences ,Internal Medicine ,Mayo Clinic ,Attending Physician ,Infectious Diseases ,Campus Benjamin Franklin ,Celiac Disease Rd Day ,Private Securities Litigation Reform Act ,Annual Report ,Investor Relations ,Corporate News ,Regulatory Announcements ,Disease ,R Amp D ,Bay ,Highlight ,Current ,Pathways ,Drug ,Development ,Unmet ,Medical ,Need ,Et Cest ,The ,Most ,Virtu ,